v3.26.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities:    
Net income (loss) $ (8,638) $ (53,110)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 16,952 13,741
Impairment of assets 0 49
Reduction in carrying amount of right-of-use asset 1,771 3,350
Lease termination 0 (14)
Stock-based compensation 30,961 25,985
Income from unconsolidated joint venture (88) (144)
Donation of common stock 4,404 2,080
Loss on debt extinguishment 0 16,430
Amortization of deferred costs on convertible notes 1,712 1,527
Deferred tax benefit (22) (44)
Changes in other assets and liabilities:    
Accounts receivable, net (55,096) (23,370)
Inventory 79 (192)
Prepaid expenses 1,039 (904)
Other assets (7,468) (1,233)
Accounts payable and accrued cost of revenue 24,009 10,728
Other accrued expenses 9,920 9,100
Contract liabilities 7,395 3,170
Lease liabilities (1,482) (5,202)
Other liabilities (54) (24)
Income taxes payable 16 (249)
Net cash provided by operating activities 25,410 1,674
Cash flows from investing activities:    
Purchases of marketable securities (341,705) (6,571)
Proceeds from sale of marketable securities 59,000 20,500
Capitalization of software development and purchases of property and equipment (38,905) (19,911)
Cash paid for business combination (4,599) 0
Net cash used in investing activities (326,209) (5,982)
Cash flows from financing activities:    
Proceeds from issuance of convertible notes 0 250,000
Costs incurred in connection with issuance of convertible notes 0 (8,650)
Payments for repurchase of convertible notes 0 (215,992)
Purchase of capped calls 0 (17,475)
Purchase of treasury stock 0 (8,080)
Proceeds from stock options exercised 6,349 2,703
Proceeds from issuance of common stock, net of underwriters' discount 248,400 0
Payment of costs related to issuance of common stock (776) 0
Proceeds from issuance of common stock under Siemens agreement 50,000 0
Net cash provided by financing activities 303,973 2,506
Effect of foreign currency translation on cash and cash equivalents (38) 415
Net increase (decrease) in cash and cash equivalents 3,136 (1,387)
Cash and cash equivalents at beginning of the period 14,996 22,232
Cash and cash equivalents at end of the period 18,132 20,845
Supplemental cash flow information:    
Cash paid for interest 1,796 2,600
Cash paid for income taxes 1,234 0
Non-cash investing and financing activities:    
Stock-based compensation included in capitalized software development costs 7,117 0
Non-cash consideration in connection with business combination 2,099 625
Non-cash purchase of property and equipment 108 74
Conversion of 2027 convertible notes to common stock $ 805 $ 0